Amgen and Genentech ‘patent dance’ continues in sealed filings

A SEALED court filing related to Amgen’s Mvasi and Genentech’s Avastin, both chemotherapy and targeted therapy drugs, was filed in U.S. District Court in Delaware Friday. / BLOOMBERG NEWS FILE PHOTO
A SEALED court filing related to Amgen’s Mvasi and Genentech’s Avastin, both chemotherapy and targeted therapy drugs, was filed in U.S. District Court in Delaware Friday. / BLOOMBERG NEWS FILE PHOTO
PROVIDENCE – A sealed lawsuit was filed in Delaware District Court Monday against Immunex Rhode Island Corp. and Amgen Inc. by Genentech Inc. and City of Hope, according to court documents. The case is related to Amgen’s Mvasi and Genentech’s Avastin, both chemotherapy and targeted-therapy drugs. The U.S. Food and Drug Administration approved Mvasi (bevacizumab-awwb)…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -